PDB Short entry for 2K9A HEADER PROTEIN BINDING 06-OCT-08 2K9A TITLE THE SOLUTION STRUCTURE OF THE ARL2 EFFECTOR, BART COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 2-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ARF-LIKE 2-BINDING PROTEIN, BINDER OF ARF2 PROTEIN 1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ARL2BP, BART, BART1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET 16B KEYWDS PROTEIN, EFFECTOR, SMALL G PROTEIN, ALTERNATIVE SPLICING, CYTOPLASM, KEYWDS 2 MITOCHONDRION, PHOSPHOPROTEIN, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 50 AUTHOR L.K.BAILEY,L.J.CAMPBELL,K.A.EVETTS,K.LITTLEFIELD,E.RAJENDRA, AUTHOR 2 D.NIETLISPACH,D.OWEN,H.R.MOTT REVDAT 6 16-MAR-22 2K9A 1 REMARK SEQADV REVDAT 5 09-JUN-09 2K9A 1 REVDAT REVDAT 4 24-FEB-09 2K9A 1 VERSN REVDAT 3 20-JAN-09 2K9A 1 JRNL REVDAT 2 18-NOV-08 2K9A 1 JRNL REVDAT 1 11-NOV-08 2K9A 0 JRNL AUTH L.K.BAILEY,L.J.CAMPBELL,K.A.EVETTS,K.LITTLEFIELD,E.RAJENDRA, JRNL AUTH 2 D.NIETLISPACH,D.OWEN,H.R.MOTT JRNL TITL THE STRUCTURE OF BINDER OF ARL2 (BART) REVEALS A NOVEL G JRNL TITL 2 PROTEIN BINDING DOMAIN: IMPLICATIONS FOR FUNCTION. JRNL REF J.BIOL.CHEM. V. 284 992 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 18981177 JRNL DOI 10.1074/JBC.M806167200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA, CNS REMARK 3 AUTHORS : LINGE, J. ET AL. (ARIA), BRUNGER, A.T. ET AL. REMARK 3 (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2K9A COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000100837. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM [U-100% 15N] PROTEIN, 50 MM REMARK 210 SODIUM PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 0.05 % SODIUM AZIDE, REMARK 210 90% H2O/10% D2O; 1 MM [U-100% REMARK 210 13C; U-100% 15N] PROTEIN, 50 MM REMARK 210 SODIUM PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 0.05 % SODIUM AZIDE, REMARK 210 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCO; 3D HNCA; 3D HN(CO)CA; REMARK 210 3D HNCACB; 3D HN(COCA)CB; 3D 1H- REMARK 210 13C NOESY; 3D HCCH-TOCSY; 3D 1H- REMARK 210 15N NOESY; 3D 1H-15N TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR ANALYSIS, AZARA, TALOS, REMARK 210 TENSOR2 REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING, MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 50 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-50 REMARK 465 RES C SSSEQI REMARK 465 HIS A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 7 -60.54 -148.91 REMARK 500 1 ALA A 10 160.50 64.05 REMARK 500 1 LEU A 11 -64.72 -94.09 REMARK 500 1 SER A 12 -28.57 -153.14 REMARK 500 1 SER A 15 -82.20 -165.83 REMARK 500 1 ASP A 18 -18.23 -167.30 REMARK 500 1 LEU A 72 -63.29 -90.10 REMARK 500 1 THR A 114 2.08 -60.95 REMARK 500 1 THR A 116 -32.96 -139.32 REMARK 500 1 ASP A 117 90.62 -63.48 REMARK 500 2 ASP A 2 -26.27 -144.76 REMARK 500 2 ALA A 3 -173.18 58.28 REMARK 500 2 SER A 8 153.49 64.68 REMARK 500 2 SER A 12 -6.19 -164.14 REMARK 500 2 PHE A 13 -74.03 -113.44 REMARK 500 2 SER A 15 -33.35 -144.95 REMARK 500 2 ASP A 54 97.52 -65.19 REMARK 500 2 LEU A 72 -62.36 -90.29 REMARK 500 2 GLU A 103 -60.01 -120.58 REMARK 500 2 ALA A 105 107.52 -54.61 REMARK 500 2 THR A 114 -3.46 -56.84 REMARK 500 2 THR A 116 -36.99 -139.81 REMARK 500 2 ASP A 117 90.71 -64.94 REMARK 500 2 ARG A 135 100.20 59.70 REMARK 500 3 ALA A 3 -13.59 -145.32 REMARK 500 3 GLU A 7 -83.14 61.90 REMARK 500 3 PHE A 13 -40.37 -131.55 REMARK 500 3 SER A 17 0.59 -67.85 REMARK 500 3 ASP A 18 -38.54 75.13 REMARK 500 3 LEU A 72 -64.31 -90.46 REMARK 500 3 ALA A 105 107.60 -56.97 REMARK 500 3 THR A 114 3.75 -63.62 REMARK 500 4 GLU A 5 -32.40 -158.33 REMARK 500 4 GLU A 7 -27.79 -160.14 REMARK 500 4 ALA A 10 -71.25 -144.86 REMARK 500 4 SER A 12 -71.28 -67.70 REMARK 500 4 SER A 15 -43.80 74.88 REMARK 500 4 LEU A 72 -63.64 -91.14 REMARK 500 4 THR A 114 -6.27 -55.06 REMARK 500 4 THR A 116 -43.12 -134.79 REMARK 500 4 ASP A 117 92.42 -63.41 REMARK 500 5 ASP A 2 95.75 58.72 REMARK 500 5 ALA A 3 1.19 -151.52 REMARK 500 5 SER A 8 -65.99 -130.53 REMARK 500 5 PHE A 9 -85.16 60.25 REMARK 500 5 PHE A 13 106.42 60.68 REMARK 500 5 GLU A 103 -49.51 -131.25 REMARK 500 5 ALA A 105 107.57 -53.99 REMARK 500 5 THR A 116 -33.56 -143.53 REMARK 500 6 GLU A 5 -173.08 58.11 REMARK 500 REMARK 500 THIS ENTRY HAS 457 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2K9A A 1 136 UNP Q9Y2Y0 AR2BP_HUMAN 1 136 SEQADV 2K9A HIS A 0 UNP Q9Y2Y0 EXPRESSION TAG SEQRES 1 A 137 HIS MET ASP ALA LEU GLU GLY GLU SER PHE ALA LEU SER SEQRES 2 A 137 PHE SER SER ALA SER ASP ALA GLU PHE ASP ALA VAL VAL SEQRES 3 A 137 GLY TYR LEU GLU ASP ILE ILE MET ASP ASP GLU PHE GLN SEQRES 4 A 137 LEU LEU GLN ARG ASN PHE MET ASP LYS TYR TYR LEU GLU SEQRES 5 A 137 PHE GLU ASP THR GLU GLU ASN LYS LEU ILE TYR THR PRO SEQRES 6 A 137 ILE PHE ASN GLU TYR ILE SER LEU VAL GLU LYS TYR ILE SEQRES 7 A 137 GLU GLU GLN LEU LEU GLN ARG ILE PRO GLU PHE ASN MET SEQRES 8 A 137 ALA ALA PHE THR THR THR LEU GLN HIS HIS LYS ASP GLU SEQRES 9 A 137 VAL ALA GLY ASP ILE PHE ASP MET LEU LEU THR PHE THR SEQRES 10 A 137 ASP PHE LEU ALA PHE LYS GLU MET PHE LEU ASP TYR ARG SEQRES 11 A 137 ALA GLU LYS GLU GLY ARG GLY HELIX 1 1 ASP A 18 MET A 33 1 16 HELIX 2 2 ASP A 34 PHE A 52 1 19 HELIX 3 3 ILE A 61 GLN A 83 1 23 HELIX 4 4 ASN A 89 LYS A 101 1 13 HELIX 5 5 ALA A 105 LEU A 113 1 9 HELIX 6 6 THR A 114 THR A 116 5 3 HELIX 7 7 ASP A 117 GLU A 133 1 17 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000